If the American public were polled about whether the government should fund research into helping children with heart defects, it’s a safe bet that this would receive overwhelming public support. And yet, The New York Times reported on the Trump administration abruptly cutting off federal funding for research at Cornell University, which halted an effort to develop a heart pump for babies and children with heart defects.
The pump has been under development for decades, but researchers said they had reached a critical moment: Before they had received a stop-work order a month ago, they had planned to soon start testing the device on sheep. ‘We’ve come to a screeching halt because we’re 100 percent dependent on this money to do this work,’ said James Antaki, a biomedical engineering professor leading the research. Unless the funding is restored within the next few months, he said, the project will be ‘cast to the four winds.’
This isn’t a situation in which the Trump administration cut funding because it thought the research was “woke.” In fact, by all accounts, the PediaFlow heart pump is completely uncontroversial.
But the White House has launched a brutal offensive against higher education in recent months, specifically targeting universities that handled pro-Palestinian student protests in ways Donald Trump didn’t like. That includes Cornell, which led the administration to withdraw, among other things, a $6.5 million research grant to help children with heart defects at a critical juncture.
NBC News’ report on this explained, “An infant’s heart is about the size of a large walnut. When a baby is born with a hole between the chambers of the heart, it can be a life-threatening condition. [Antaki created] a AA battery-sized device that uses a rotating propeller on magnets to increase blood flow, helping them to survive surgery or live at home with their family until a donor heart is available, if needed.”
The grant that Cornell expected to receive, the NBC News report added, would have supported “further testing of the prototype, including placement in an animal to ensure it won’t harm humans, and completion of the mountain of paperwork needed to move through the Food and Drug Administration’s regulatory process.”
It’s still possible that the administration could reverse course on this — it’s happened many times since the president returned to power — but for now, this potentially lifesaving research is on indefinite hold, not because it lacks merit, but because the White House has a culture war to fight.








